# VITAL Platform: Comprehensive Pharma Ontology Seeding Plan

## Date: 2025-11-29
## Version: 1.0
## Status: IN PROGRESS

---

## Executive Summary

This plan outlines the systematic approach to populate the VITAL platform's enterprise ontology with rich, evidence-based pharmaceutical industry data. The seeding follows a **top-down hierarchical approach** to ensure referential integrity and logical data flow.

---

## Seeding Hierarchy (Top-Down Order)

```
Level 1: STRATEGIC LAYER
├── 1.1 Strategic Themes (3-5 themes)
├── 1.2 Strategic Pillars (4-6 pillars per theme)
└── 1.3 Strategic Priorities (3-5 priorities per pillar)

Level 2: OKR LAYER
├── 2.1 Company-Level Objectives (5-7 objectives)
├── 2.2 Functional OKRs (per function)
└── 2.3 Key Results (3-5 per objective)

Level 3: L0 DOMAIN KNOWLEDGE
├── 3.1 Therapeutic Areas (15-20 areas)
├── 3.2 Diseases (50-100 per therapeutic area)
├── 3.3 Products (representative portfolio)
├── 3.4 Evidence Types (15-20 types)
└── 3.5 Regulatory Frameworks (major markets)

Level 4: ORGANIZATIONAL STRUCTURE
├── 4.1 Functions (15 pharma functions)
├── 4.2 Departments (5-10 per function)
└── 4.3 Roles (3-8 per department)

Level 5: PERSONAS
├── 5.1 Persona Archetypes (4 MECE per role)
└── 5.2 Persona Attributes (behavioral deltas)

Level 6: JTBD ENRICHMENT
├── 6.1 Job Statements (ODI format)
├── 6.2 Pain Points
├── 6.3 Success Criteria
├── 6.4 Desired Outcomes
└── 6.5 AI Suitability Scores
```

---

## Detailed Seeding Topics

### LEVEL 1: STRATEGIC LAYER

#### 1.1 Strategic Themes
| Topic | Research Query | Evidence Sources |
|-------|---------------|------------------|
| Digital Transformation | "pharma digital transformation strategy 2025" | ZS, McKinsey, Deloitte |
| Patient Centricity | "patient-centric pharma strategy 2025" | MAPS, DIA, industry reports |
| AI & Data | "AI in pharmaceutical industry strategy" | BCG, Accenture, IQVIA |
| Operational Excellence | "pharma operational excellence cost optimization" | PwC, Strategy& |
| Scientific Innovation | "R&D innovation pharmaceutical strategy" | Nature, industry journals |

**Status:** ⬜ Not Started

#### 1.2 Strategic Pillars
| Theme | Pillars to Research |
|-------|---------------------|
| Digital Transformation | Cloud, Data Analytics, AI/ML, Digital Trials, Connected Health |
| Patient Centricity | Patient Engagement, Patient Outcomes, Health Literacy, Access |
| Scientific Innovation | Discovery, Clinical Development, Real-World Evidence, Precision Medicine |

**Status:** ⬜ Not Started

#### 1.3 Strategic Priorities
Research specific initiatives and programs that support each pillar.

**Status:** ⬜ Not Started

---

### LEVEL 2: OKR LAYER

#### 2.1 Company-Level OKRs
| Function | Research Query |
|----------|---------------|
| R&D | "pharmaceutical R&D OKR objectives metrics" |
| Commercial | "pharma commercial OKR sales revenue" |
| Medical Affairs | "medical affairs KPI OKR objectives" |
| Market Access | "market access OKR pricing reimbursement" |
| Regulatory | "regulatory affairs OKR submission approval" |
| Manufacturing | "pharma manufacturing OKR quality efficiency" |

**Status:** ⬜ Not Started

---

### LEVEL 3: L0 DOMAIN KNOWLEDGE

#### 3.1 Therapeutic Areas
| Category | Areas to Seed |
|----------|--------------|
| Oncology | Solid tumors, Hematological cancers, Immuno-oncology |
| Immunology | Rheumatology, Dermatology, Gastroenterology |
| Neurology | CNS disorders, Psychiatry, Pain management |
| Cardiology | CV diseases, Heart failure, Arrhythmia |
| Metabolic | Diabetes, Obesity, NASH |
| Rare Diseases | Genetic disorders, Orphan diseases |
| Infectious | Vaccines, Anti-infectives, HIV |

**Status:** ⬜ Not Started

#### 3.2 Diseases (with ICD-10/MeSH codes)
| Research Query |
|---------------|
| "top 50 diseases pharmaceutical industry ICD-10 codes" |
| "rare diseases orphan drug FDA EMA" |
| "oncology cancer types ICD-10 classification" |

**Status:** ⬜ Not Started

#### 3.3 Products (representative)
| Research Query |
|---------------|
| "top pharmaceutical drugs 2024 2025 sales revenue" |
| "blockbuster drugs mechanism of action" |
| "drug lifecycle stages pharmaceutical" |

**Status:** ⬜ Not Started

#### 3.4 Evidence Types
| Research Query |
|---------------|
| "evidence hierarchy pharmaceutical clinical trials" |
| "real world evidence FDA EMA guidance" |
| "GRADE evidence levels systematic review" |

**Status:** ⬜ Not Started

#### 3.5 Regulatory Frameworks
| Research Query |
|---------------|
| "FDA drug approval pathways NDA BLA 505b2" |
| "EMA regulatory pathways centralized procedure" |
| "ICH guidelines pharmaceutical regulatory" |

**Status:** ⬜ Not Started

---

### LEVEL 4: ORGANIZATIONAL STRUCTURE

#### 4.1 Functions (15 Core Pharma Functions)
| Function | Departments |
|----------|-------------|
| Research & Development | Discovery, Preclinical, Clinical Development, Biostatistics |
| Medical Affairs | MSL, Medical Information, Publications, Medical Education |
| Commercial | Sales, Marketing, Brand Management, Sales Operations |
| Market Access | HEOR, Pricing, Payer Relations, Government Affairs |
| Regulatory Affairs | Submissions, Compliance, Labeling, CMC Regulatory |
| Pharmacovigilance | Safety Surveillance, Risk Management, Signal Detection |
| Manufacturing | Production, QA/QC, Supply Chain, Engineering |
| Quality | Quality Systems, Auditing, Compliance, Validation |
| Legal | IP, Contracts, Litigation, Compliance |
| Finance | FP&A, Accounting, Treasury, Tax |
| HR | Talent, L&D, Compensation, HRBP |
| IT | Infrastructure, Applications, Data, Security |
| Corporate Affairs | Communications, Investor Relations, ESG |
| Business Development | M&A, Licensing, Partnerships, Alliance Management |
| Clinical Operations | Site Management, CRO Management, Trial Supply |

**Status:** ⬜ Not Started

#### 4.2 & 4.3 Departments & Roles
Research specific roles and responsibilities for each function.

**Status:** ⬜ Not Started

---

### LEVEL 5: PERSONAS

#### 5.1 MECE Persona Framework (2x2 Matrix)
| | Low Complexity | High Complexity |
|---|----------------|-----------------|
| **High AI Maturity** | AUTOMATOR | ORCHESTRATOR |
| **Low AI Maturity** | LEARNER | SKEPTIC |

#### 5.2 Persona Attributes per Role
| Attribute | Research Source |
|-----------|----------------|
| AI Maturity Scores | Industry surveys, digital adoption reports |
| Work Complexity | Job descriptions, role requirements |
| Pain Points | User research, industry forums |
| Communication Style | Professional communication research |
| Decision Making | Behavioral research |

**Status:** ⬜ Not Started

---

### LEVEL 6: JTBD ENRICHMENT

#### 6.1 Job Statement Format (ODI)
```
WHEN [situation/trigger]
I WANT TO [action/job]
SO THAT [desired outcome]
```

#### 6.2 Research by Function
| Function | JTBD Research Query |
|----------|---------------------|
| Medical Affairs | "MSL jobs to be done scientific exchange KOL" |
| Market Access | "market access JTBD pricing reimbursement payer" |
| Commercial | "pharma sales JTBD customer engagement" |
| Regulatory | "regulatory affairs JTBD submission approval FDA" |

**Status:** ⬜ Not Started

---

## Research Protocol

### For Each Topic:
1. **Primary Search**: Industry-specific query
2. **Evidence Collection**: Capture sources, citations, statistics
3. **Data Structuring**: Format for database insertion
4. **Validation**: Cross-reference multiple sources
5. **Migration Creation**: Generate SQL with evidence in metadata

### Evidence Quality Criteria:
- ✅ Peer-reviewed or industry reports (IQVIA, McKinsey, BCG)
- ✅ Regulatory guidance (FDA, EMA, ICH)
- ✅ Professional associations (MAPS, DIA, ISPE)
- ✅ Recent data (2023-2025 preferred)
- ❌ Blog posts without citations
- ❌ Single-source claims

---

## Execution Order

| Phase | Topics | Priority |
|-------|--------|----------|
| **Phase 1** | 1.1 Strategic Themes | P0 |
| **Phase 2** | 1.2 Strategic Pillars | P0 |
| **Phase 3** | 3.1 Therapeutic Areas | P0 |
| **Phase 4** | 3.4 Evidence Types | P1 |
| **Phase 5** | 3.5 Regulatory Frameworks | P1 |
| **Phase 6** | 2.1-2.3 OKRs | P1 |
| **Phase 7** | 1.3 Strategic Priorities | P2 |
| **Phase 8** | 3.2 Diseases | P2 |
| **Phase 9** | 3.3 Products | P2 |
| **Phase 10** | 5.1-5.2 Personas | P2 |
| **Phase 11** | 6.1-6.5 JTBD Enrichment | P3 |

---

## Next Steps

1. ⬜ **Phase 1**: Research Strategic Themes with targeted queries
2. ⬜ Create migration `20251129_036_strategic_themes_seed.sql`
3. ⬜ Continue through phases sequentially

---

*Generated by VITAL Platform Ontology Seeding System*
